Abrysvo

European Commission amends marketing authorisation for Pfizer’s ABRYSVO vaccine, extending RSV protection to adults 18 and older…

First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower…

Pfizer's RSV vaccine, Abrysvo, approved by the FDA just weeks after Arexvy, is likely to show GSK significant competition